LAUREN SHARP: Open Payments
NPI 1639636467 · WARSAW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 31 payments from 10 companies in 2025. Trend: 2023 $146 · 2024 $256 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $182 |
| Medtronic, Inc. | 8 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Gilead Sciences, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ABIOMED | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: VRAYLAR, MAVYRET, CD HORIZON SPINAL SYSTEM, INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM, Kerendia, ZEVO ANTERIOR CERVICAL PLATE SYSTEM, PIVOX OBLIQUE LATERAL SPINAL SYSTEM, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
